Three-Month Sustained-Release Form of Triptorelin in Patients with Advanced Prostatic Adenocarcinoma: Results of an Open Pharmacodynamic and Pharmacokinetic Multicenter Study

Publisher： Karger

E-ISSN： 1663-2826|50|2|89-93

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.50, Iss.2, 1998-08, pp. : 89-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of Lanreotide

By  

Neuroendocrinology, Vol. 80, Iss. 4, 2005-01 ,pp. : 244-251

Karger

Access to resources Recommend Favorite

Meta-Analysis of Paediatric Patients with Central Precocious Puberty Treated with Intramuscular Triptorelin 11.25 mg 3-Month Prolonged-Release Formulation


By  

Hormone Research in Paediatrics, Vol. 87, Iss. 4, 2017-03 ,pp. : 224-232

Karger

Access to resources Recommend Favorite

Pharmacodynamic Equivalence of a Decapeptyl 3-Month SR Formulation with the 28-Day SR Formulation in Patients with Advanced Prostate Cancer

By  

Hormone Research in Paediatrics, Vol. 62, Iss. 5, 2004-11 ,pp. : 252-258

Karger

Access to resources Recommend Favorite

Analyses of Treatment Variables for Patients with Childhood Craniopharyngioma – Results of the Multicenter Prospective Trial KRANIOPHARYNGEOM 2000 after Three Years of Follow-Up

By  

Hormone Research in Paediatrics, Vol. 73, Iss. 3, 2010-03 ,pp. : 175-180

Karger

Access to resources Recommend Favorite

Long-Term Suppression of Pituitary-Gonadal Function with Three-Month Depot of Leuprorelin Acetate in a Girl with Central Precocious Puberty

By  

Hormone Research in Paediatrics, Vol. 58, Iss. 6, 2002-11 ,pp. : 292-296

Karger

Access to resources Recommend Favorite